Company Filing History:
Years Active: 2023
Title: Innovations in Cancer Treatment by Josh Lauring
Introduction
Josh Lauring is an accomplished inventor based in Towson, MD (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic methods. His work focuses on utilizing PRMT5 inhibitors to provide effective treatment options for patients diagnosed with cancer.
Latest Patents
Josh Lauring holds a patent for "Methods of treating cancer using PRMT5 inhibitors." This patent outlines methods for treating human patients diagnosed with cancer by administering a therapeutically effective amount of a PRMT5 inhibitor. The methods include initial doses of at least about 0.1 mg per day of the PRMT5 inhibitor for an initial dosing period of about 5 to 21 days, followed by subsequent doses for additional periods. This innovative approach aims to improve treatment outcomes for cancer patients.
Career Highlights
Josh Lauring is currently associated with Janssen Pharmaceutica NV, where he continues to advance his research in cancer therapies. His dedication to improving patient care through innovative treatments has positioned him as a notable figure in the pharmaceutical industry.
Collaborations
Josh collaborates with talented professionals in his field, including Hillary Joy Millar Quinn and Kathryn Elizabeth Packman. These collaborations enhance the research and development efforts at Janssen Pharmaceutica NV, contributing to the advancement of cancer treatment methodologies.
Conclusion
Josh Lauring's innovative work in developing methods for treating cancer using PRMT5 inhibitors showcases his commitment to improving patient outcomes. His contributions to the field of oncology are significant and reflect the importance of continued research and innovation in medical treatments.